Pfizer and BioNTech announced Wednesday that their coronavirus vaccine was found to be 100% effective at protecting against COVID-19 in a trial of more than 2,200 children between the ages of 12 and 15.
The big picture: Pfizer CEO Albert Bourla said the companies plan to submit clinical trial data to the FDA for emergency use authorization in the coming weeks, with the hope of vaccinations for adolescents beginning before the start of the next school year.
- The trial’s data will also be submitted to the European Medicines Agency (EMA) for emergency use authorization. Continue reading.